"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."
Sir John Bell
- Home
- Fundraising
-
About Us
- Founders
- News
- The Trials Acceleration Programme (TAP)
- Our TAP Centres and Nurses
- Where Your Money Goes
- What Our Nurses Do
- Professor Charlie Craddock CBE
- Corporate Partnerships
- Our Trustees and Patrons
- Deutsche Bank Partnership
- The Cure Leukaemia Team
- Publications
- Privacy Policy
- Join The #CLFamily
- Sustainability Policy
- About Leukaemia
- Patient Stories
- The Tour 21
- London 2 Paris 2021
Menu
Fundraising
About Us
About Leukaemia
Patient Stories
The Tour 21
London 2 Paris 2021
- Founders
- News
- The Trials Acceleration Programme (TAP)
- Our TAP Centres and Nurses
- Where Your Money Goes
- What Our Nurses Do
- Professor Charlie Craddock CBE
- Corporate Partnerships
- Our Trustees and Patrons
- Deutsche Bank Partnership
- The Impact Of One Day
- A Message From Cure Leukaemia co-founder Professor Charlie Craddock CBE
- Deutsche Bank's £2m Positive Impact
- Patient Stories
- Working Together - Events To Excite And Engage
- Let's Get Social
- Well-Known Figures Show Their Support For Cure Leukaemia
- The Cure Leukaemia Team
- Publications
- Privacy Policy
- Join The #CLFamily
- Sustainability Policy
Our Trustees and Patrons
.jpg)
Cure Leukaemia was founded in 2003 by Professor Charlie Craddock CBE and two patients, Graham Silk and Michael Woolley. Cure Leukaemia is governed by a board of dedicated Trustees composed of the 8 members below.
Board of Trustees
.png)
Patrons
